Search

for
Search:

GlossaryDiphenylcyclopropenone (DCP)

topical immunotherapy agent used to treat alopecia areata

Diphenylcyclopropenone (DPCP) is a topical immunotherapy agent used primarily to treat alopecia areata, a condition that causes hair loss. It works by inducing a mild allergic reaction on the scalp, which is thought to distract the immune system from attacking hair follicles, thereby promoting hair regrowth.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 103 results

research Diphenylcyclopropenone Treatment Outcomes for Alopecia Areata

1 citations, February 2023 in “Deleted Journal”

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

research Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis

4 citations, August 2013 in “Case reports in dermatology”

A patient with total hair loss developed vitiligo after using a treatment called DCP.

research Changes in Distribution Pattern of CD8 Lymphocytes in the Scalp in Alopecia Areata During Treatment With Diphenylcyclopropenone

27 citations, May 2007 in “Archives of dermatological research”

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

research Efficacy and Tolerance of 2,3-Diphenylcyclopropenone in Propylene Glycol Versus Isopropanol for Treating Alopecia Areata

January 2017 in “Nasza Dermatologia Online”

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

research Tropical Diphencyprone Therapy in Alopecia Totalis

5 citations, July 1988 in “British journal of dermatology/British journal of dermatology, Supplement”

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

View more "dcp" in research →

Community Join

0 / 0 results

— no results